Results 31 to 40 of about 9,946 (182)

The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression [PDF]

open access: yesNephrology Dialysis Transplantation, 2011
The fundamental insights into uraemic toxicity have evolved little since publication of the classical monograph by Cushny nearly a century ago [1]. Organic metabolites are still thought to substantially contribute to uremia (albeit urea might not be the culprit), yet evidence unequivocally demonstrating toxicity of any single uraemic constituent is ...
Björn K I, Meijers, Pieter, Evenepoel
openaire   +2 more sources

Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients. [PDF]

open access: yesJ Clin Med Res, 2017
Beside the phosphate binding effect, non-calcium non-aluminum phosphate binder, namely sevelamer hydrochloride (SH), has many other effects in dialysis patients. It can absorb many other compounds, decrease low-density lipoprotein cholesterol (LDL-C) level, and attenuate the progression of vascular calcification; it has been reported to have anti ...
Lin CJ   +6 more
europepmc   +4 more sources

Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers

open access: yesToxins, 2023
The objective of the present study was to investigate the putative correlation between the saliva concentration and free serum concentration for 10 uremic toxins (UTs; eight protein-bound solutes: 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF),
Nicolas Fabresse   +6 more
doaj   +1 more source

Removal of Protein-Bound Uremic Toxins Using Binding Competitors in Hemodialysis: A Narrative Review

open access: yesToxins, 2021
Removal of protein-bound uremic toxins (PBUTs) during conventional dialysis is insufficient. PBUTs are associated with comorbidities and mortality in dialysis patients.
Vaibhav Maheshwari   +3 more
doaj   +1 more source

Atorvastatin attenuates p‑cresyl sulfate‑induced atherogenesis and plaque instability in ApoE knockout mice. [PDF]

open access: yesMol Med Rep, 2016
p-cresyl sulfate (PCS) is a protein-bound uremic toxin retained in the blood of patients with chronic kidney disease (CKD) As atherosclerosis is a primary cardiovascular complication for patients with CKD, the aim of the present study was to investigate the mechanisms underlying the aggravation of atherosclerosis by PCS.
Han H   +5 more
europepmc   +4 more sources

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients [PDF]

open access: yes, 2017
Background and aim : Numerous outcome studies and interventional trials in hemodialysis (HD) patients are based on uremic toxin concentrations determined at one single or a limited number of time points.
Delrue, Willem   +7 more
core   +13 more sources

Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS. [PDF]

open access: yesJ Food Drug Anal, 2019
Chronic kidney disease (CKD) is a complex disorder that affects multiple organs and increases the risk of cardiovascular complications. CKD affects approximately 12% of the population in Taiwan. Loss of kidney function leads to accumulation of potentially toxic compounds such as indoxyl sulfate (IS) and p-cresyl sulfate (pCS), two protein-bound uremic ...
Lin CN   +5 more
europepmc   +3 more sources

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study). [PDF]

open access: yesJ Clin Med, 2019
Di Iorio BR   +12 more
europepmc   +2 more sources

MO277: Effect of P-Cresyl Sulfate in Cardiorenal Axis in Mice

open access: yesNephrology Dialysis Transplantation, 2022
Abstract BACKGROUND AND AIMS Uremic toxins (UT) are extremely relevant for the understanding of pathologies of the cardiovascular system once kidney and heart have a close relationship and share different functions.
Carlos Alexandre Falconi   +5 more
openaire   +1 more source

Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

open access: yesBiomolecules, 2023
Diabetic kidney disease (DKD) is one of the most debilitating complications of type 2 diabetes mellitus (T2DM), as it progresses silently to end-stage renal disease (ESRD). The discovery of novel biomarkers of early DKD becomes acute, as its incidence is
Lavinia Balint   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy